View in EDS HTML Full Text PDF Full Text

Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2EV Study.

Saved in:
Bibliographic Details
Title: Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2EV Study.
Authors: Fiala O; Department of Oncology and Radiotherapeutics, Faculty of Medicine, University Hospital in Pilsen, Charles University, alej Svobody 80, 30460, Pilsen, Czech Republic. fialao@fnplzen.cz.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. fialao@fnplzen.cz., Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Basso U; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, 35128, Padova, Italy., Giannatempo P; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, Milan, Italy., Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain., Buti S; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Myint ZW; Division of Medical Oncology, Department of Internal Medicine, Markey Cancer Center, University of Kentucky, Lexington, KY, USA., De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Pichler R; Department of Urology, Medical University of Innsbruck, Innsbruck, Austria., Grillone F; Unità Operativa di Oncologia Presidio Pugliese-Ciaccio Azienda Ospedaliera Universitaria Renato Dulbecco, Catanzaro, Italy., Ürün Y; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey., Calabrò F; Medical Oncology, 1-IRCCS Regina Elena National Cancer Institute, Rome, Italy., Bourlon MT; Department of Hemato-Oncology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.; Escuela de Medicina, Universidad Panamericana, Mexico City, Mexico., Galli L; Medical Oncology Unit 2, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy., Kanesvaran R; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Roviello G; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini, 6, Florence, Italy., Kucharz J; Department of Uro-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Warsaw, Poland., Rizzo M; Medical Oncology Unit, Azienda Ospedaliera Universitaria Consorziale Policlinico di Bari, Bari, Italy., Park SH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Cerbone L; Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy., Seront E; Department of Medical Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Messina C; Oncology Unit, A.R.N.A.S. Civico, Palermo, Italy., Molina-Cerrillo J; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain., Santini D; Oncologia, Dip, Scienze e Biotecnologie Medico-chirurgiche, Policlinico Umberto 1, Rome, Italy., Yano A; Department of Urology, Saitama Medical Center, Saitama Medical University, Saitama, Japan., Incorvaia L; Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), Section of Medical Oncology, University of Palermo, Palermo, Italy., Catalano M; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Pinto A; Servicio de Oncología, Hospital Universitario La Paz, Madrid, Spain., Formisano L; Department of Medicine and Surgery, Federico II University, Naples, Italy., Soares A; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.; Centro Paulista de Oncologia/Oncoclínicas, São Paulo, SP, Brazil., Facchini G; Oncology Unit, 'S. Maria Delle Grazie' Hospital, ASL NA2 NORD, Pozzuoli, Naples, Italy., Fornarini G; IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Poprach A; Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic., Rebuzzi SE; Medical Oncology Unit, Ospedale San Paolo, Savona, Italy.; Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, Genoa, Italy., Nasso C; Medical Oncology, Ospedale Santa Corona, Pietra Ligure, Italy., Spinelli GP; UOC Oncologia Territoriale Ausl Latina, Aprilia, Italy., Angel M; Clinical Oncology, Genitourinary Oncology Unit, Alexander Fleming Institute, Buenos Aires, Argentina., Stellato M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, Milan, Italy., Tural D; Department of Medical Oncology, Bakirköy Dr. SadiKonuk Training and Research Hospital, Tevfik, Bakirkoy, Istanbul, Turkey., Aurilio G; Division of Cancer Prevention and Genetics, IEO European Institute of Oncology IRCCS, Milan, Italy., Epstein I; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Carrozza F; Oncology Unit, Department of Oncology and Hematology, Santa Maria delle Croci Hospital, AUSL Romagna, Ravenna, Italy., Monteiro FSM; Hospital Sírio-Libanês, Brasília, DF, Brazil.; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil., Benedetti G; U.O. Oncologia, Ospedale di Civitanova Marche, Civitanova Marche, Italy., Büchler T; Department of Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Ortega C; Dipartimento di Oncologia, Ospedale San Lazzaro, Azienda sanitaria locale CN2, Alba, Cuneo, Italy., Zakopoulou R; 2nd Propaedeutic Department of Internal Medicine, School of Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, Athens, Greece., Battelli N; Medical Oncology Unit, Macerata Hospital, Macerata, Italy., Porta C; Interdisciplinary Department of Medicina, Division of Medical Oncology, University of Bari 'Aldo Moro', A.O.U. Consorziale Policlinico di Bari, Bari, Italy., Bellmunt J; Harvard Medical School, Boston, MA, USA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Gupta S; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Santoni M; Medical Oncology Unit, Macerata Hospital, Macerata, Italy.
Source: Targeted oncology [Target Oncol] 2024 Nov; Vol. 19 (6), pp. 905-915. Date of Electronic Publication: 2024 Oct 01.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39354179
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2<superscript>EV</superscript> Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fiala+O%22">Fiala O</searchLink>; Department of Oncology and Radiotherapeutics, Faculty of Medicine, University Hospital in Pilsen, Charles University, alej Svobody 80, 30460, Pilsen, Czech Republic. fialao@fnplzen.cz.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. fialao@fnplzen.cz.<br /><searchLink fieldCode="AU" term="%22Massari+F%22">Massari F</searchLink>; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Basso+U%22">Basso U</searchLink>; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, 35128, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Giannatempo+P%22">Giannatempo P</searchLink>; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Grande+E%22">Grande E</searchLink>; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Buti+S%22">Buti S</searchLink>; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.<br /><searchLink fieldCode="AU" term="%22Myint+ZW%22">Myint ZW</searchLink>; Division of Medical Oncology, Department of Internal Medicine, Markey Cancer Center, University of Kentucky, Lexington, KY, USA.<br /><searchLink fieldCode="AU" term="%22De+Giorgi+U%22">De Giorgi U</searchLink>; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.<br /><searchLink fieldCode="AU" term="%22Pichler+R%22">Pichler R</searchLink>; Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Grillone+F%22">Grillone F</searchLink>; Unità Operativa di Oncologia Presidio Pugliese-Ciaccio Azienda Ospedaliera Universitaria Renato Dulbecco, Catanzaro, Italy.<br /><searchLink fieldCode="AU" term="%22Ürün+Y%22">Ürün Y</searchLink>; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.<br /><searchLink fieldCode="AU" term="%22Calabrò+F%22">Calabrò F</searchLink>; Medical Oncology, 1-IRCCS Regina Elena National Cancer Institute, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Bourlon+MT%22">Bourlon MT</searchLink>; Department of Hemato-Oncology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.; Escuela de Medicina, Universidad Panamericana, Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Galli+L%22">Galli L</searchLink>; Medical Oncology Unit 2, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.<br /><searchLink fieldCode="AU" term="%22Kanesvaran+R%22">Kanesvaran R</searchLink>; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Roviello+G%22">Roviello G</searchLink>; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini, 6, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Kucharz+J%22">Kucharz J</searchLink>; Department of Uro-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Rizzo+M%22">Rizzo M</searchLink>; Medical Oncology Unit, Azienda Ospedaliera Universitaria Consorziale Policlinico di Bari, Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Park+SH%22">Park SH</searchLink>; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Cerbone+L%22">Cerbone L</searchLink>; Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Seront+E%22">Seront E</searchLink>; Department of Medical Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Messina+C%22">Messina C</searchLink>; Oncology Unit, A.R.N.A.S. Civico, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Molina-Cerrillo+J%22">Molina-Cerrillo J</searchLink>; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Santini+D%22">Santini D</searchLink>; Oncologia, Dip, Scienze e Biotecnologie Medico-chirurgiche, Policlinico Umberto 1, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Yano+A%22">Yano A</searchLink>; Department of Urology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.<br /><searchLink fieldCode="AU" term="%22Incorvaia+L%22">Incorvaia L</searchLink>; Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), Section of Medical Oncology, University of Palermo, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Catalano+M%22">Catalano M</searchLink>; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Pinto+A%22">Pinto A</searchLink>; Servicio de Oncología, Hospital Universitario La Paz, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Formisano+L%22">Formisano L</searchLink>; Department of Medicine and Surgery, Federico II University, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Soares+A%22">Soares A</searchLink>; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.; Centro Paulista de Oncologia/Oncoclínicas, São Paulo, SP, Brazil.<br /><searchLink fieldCode="AU" term="%22Facchini+G%22">Facchini G</searchLink>; Oncology Unit, 'S. Maria Delle Grazie' Hospital, ASL NA2 NORD, Pozzuoli, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Fornarini+G%22">Fornarini G</searchLink>; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Poprach+A%22">Poprach A</searchLink>; Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Rebuzzi+SE%22">Rebuzzi SE</searchLink>; Medical Oncology Unit, Ospedale San Paolo, Savona, Italy.; Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Nasso+C%22">Nasso C</searchLink>; Medical Oncology, Ospedale Santa Corona, Pietra Ligure, Italy.<br /><searchLink fieldCode="AU" term="%22Spinelli+GP%22">Spinelli GP</searchLink>; UOC Oncologia Territoriale Ausl Latina, Aprilia, Italy.<br /><searchLink fieldCode="AU" term="%22Angel+M%22">Angel M</searchLink>; Clinical Oncology, Genitourinary Oncology Unit, Alexander Fleming Institute, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Stellato+M%22">Stellato M</searchLink>; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Tural+D%22">Tural D</searchLink>; Department of Medical Oncology, Bakirköy Dr. SadiKonuk Training and Research Hospital, Tevfik, Bakirkoy, Istanbul, Turkey.<br /><searchLink fieldCode="AU" term="%22Aurilio+G%22">Aurilio G</searchLink>; Division of Cancer Prevention and Genetics, IEO European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Epstein+I%22">Epstein I</searchLink>; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Carrozza+F%22">Carrozza F</searchLink>; Oncology Unit, Department of Oncology and Hematology, Santa Maria delle Croci Hospital, AUSL Romagna, Ravenna, Italy.<br /><searchLink fieldCode="AU" term="%22Monteiro+FSM%22">Monteiro FSM</searchLink>; Hospital Sírio-Libanês, Brasília, DF, Brazil.; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.<br /><searchLink fieldCode="AU" term="%22Benedetti+G%22">Benedetti G</searchLink>; U.O. Oncologia, Ospedale di Civitanova Marche, Civitanova Marche, Italy.<br /><searchLink fieldCode="AU" term="%22Büchler+T%22">Büchler T</searchLink>; Department of Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Ortega+C%22">Ortega C</searchLink>; Dipartimento di Oncologia, Ospedale San Lazzaro, Azienda sanitaria locale CN2, Alba, Cuneo, Italy.<br /><searchLink fieldCode="AU" term="%22Zakopoulou+R%22">Zakopoulou R</searchLink>; 2nd Propaedeutic Department of Internal Medicine, School of Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Battelli+N%22">Battelli N</searchLink>; Medical Oncology Unit, Macerata Hospital, Macerata, Italy.<br /><searchLink fieldCode="AU" term="%22Porta+C%22">Porta C</searchLink>; Interdisciplinary Department of Medicina, Division of Medical Oncology, University of Bari 'Aldo Moro', A.O.U. Consorziale Policlinico di Bari, Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Bellmunt+J%22">Bellmunt J</searchLink>; Harvard Medical School, Boston, MA, USA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Gupta+S%22">Gupta S</searchLink>; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Santoni+M%22">Santoni M</searchLink>; Medical Oncology Unit, Macerata Hospital, Macerata, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101270595%22">Targeted oncology</searchLink> [Target Oncol] 2024 Nov; Vol. 19 (6), pp. 905-915. <i>Date of Electronic Publication: </i>2024 Oct 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+France%22">Springer-Verlag France </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>101270595 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1776-260X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217762596%22">17762596 </searchLink><i>NLM ISO Abbreviation: </i>Target Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39354179
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s11523-024-01099-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 905
    Titles:
      – TitleFull: Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2EV Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fiala O
      – PersonEntity:
          Name:
            NameFull: Massari F
      – PersonEntity:
          Name:
            NameFull: Basso U
      – PersonEntity:
          Name:
            NameFull: Giannatempo P
      – PersonEntity:
          Name:
            NameFull: Grande E
      – PersonEntity:
          Name:
            NameFull: Buti S
      – PersonEntity:
          Name:
            NameFull: Myint ZW
      – PersonEntity:
          Name:
            NameFull: De Giorgi U
      – PersonEntity:
          Name:
            NameFull: Pichler R
      – PersonEntity:
          Name:
            NameFull: Grillone F
      – PersonEntity:
          Name:
            NameFull: Ürün Y
      – PersonEntity:
          Name:
            NameFull: Calabrò F
      – PersonEntity:
          Name:
            NameFull: Bourlon MT
      – PersonEntity:
          Name:
            NameFull: Galli L
      – PersonEntity:
          Name:
            NameFull: Kanesvaran R
      – PersonEntity:
          Name:
            NameFull: Roviello G
      – PersonEntity:
          Name:
            NameFull: Kucharz J
      – PersonEntity:
          Name:
            NameFull: Rizzo M
      – PersonEntity:
          Name:
            NameFull: Park SH
      – PersonEntity:
          Name:
            NameFull: Cerbone L
      – PersonEntity:
          Name:
            NameFull: Seront E
      – PersonEntity:
          Name:
            NameFull: Messina C
      – PersonEntity:
          Name:
            NameFull: Molina-Cerrillo J
      – PersonEntity:
          Name:
            NameFull: Santini D
      – PersonEntity:
          Name:
            NameFull: Yano A
      – PersonEntity:
          Name:
            NameFull: Incorvaia L
      – PersonEntity:
          Name:
            NameFull: Catalano M
      – PersonEntity:
          Name:
            NameFull: Pinto A
      – PersonEntity:
          Name:
            NameFull: Formisano L
      – PersonEntity:
          Name:
            NameFull: Soares A
      – PersonEntity:
          Name:
            NameFull: Facchini G
      – PersonEntity:
          Name:
            NameFull: Fornarini G
      – PersonEntity:
          Name:
            NameFull: Poprach A
      – PersonEntity:
          Name:
            NameFull: Rebuzzi SE
      – PersonEntity:
          Name:
            NameFull: Nasso C
      – PersonEntity:
          Name:
            NameFull: Spinelli GP
      – PersonEntity:
          Name:
            NameFull: Angel M
      – PersonEntity:
          Name:
            NameFull: Stellato M
      – PersonEntity:
          Name:
            NameFull: Tural D
      – PersonEntity:
          Name:
            NameFull: Aurilio G
      – PersonEntity:
          Name:
            NameFull: Epstein I
      – PersonEntity:
          Name:
            NameFull: Carrozza F
      – PersonEntity:
          Name:
            NameFull: Monteiro FSM
      – PersonEntity:
          Name:
            NameFull: Benedetti G
      – PersonEntity:
          Name:
            NameFull: Büchler T
      – PersonEntity:
          Name:
            NameFull: Ortega C
      – PersonEntity:
          Name:
            NameFull: Zakopoulou R
      – PersonEntity:
          Name:
            NameFull: Battelli N
      – PersonEntity:
          Name:
            NameFull: Porta C
      – PersonEntity:
          Name:
            NameFull: Bellmunt J
      – PersonEntity:
          Name:
            NameFull: Gupta S
      – PersonEntity:
          Name:
            NameFull: Santoni M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2024 Nov
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1776-260X
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Targeted oncology
              Type: main
ResultId 1